The Taiwanese Dermatological Association (TDA) was founded in the 2nd of February, 1975 by a group of dermatologists, Drs/Professor Yau-Chin Lu、Tsu-Chieh Shen、Hua-Min Weng, who saw the necessity of networking in a growing membership and with international dermatology organizations.
TDA is the official organization for Taiwan dermatologist that is responsible for the development and supervision of dermatology residency training program. Over the past 40 years, TDA has grown into a large organization with more than 1,000 members. The members include dermatologists from the medical center, government, university and private practice, and researchers in basic dermatological science. The members of TDA are actively involved in international collaborative research projects including studies on cutaneous drug hypersensitivity, psoriasis, vitiligo and arsenic poisoning. With quite a number of internationally renowned speakers in basic research, drug adverse reaction, cosmetic laser, injectable, and skin surgery, TDA plays a leading role in the development of dermatology science and aesthetic medicine across Asia. TDA published the first issue of Dermatologica Sinica in 1983. Now is a quarterly publication. Dermatologica Sinica was included in the Science Citation Index Expanded in year 2008, which is a welcome recognition of its achievements.
The Dermatologica Sinica (DS) is the official peer-reviewed publication of the Taiwanese Dermatological Association and Taiwanese Society for Investigative Dermatology. It is published quarterly by Wolters Kluwer - Medknow.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, SCOPUS, Science Citation Index Expanded
as reported in the 2021 Journal Citation Reports®
(Clarivate Analytics, 2022): 1.107
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
Dermatologica Sinica aims to publish high quality scientific research in the field of dermatology, with the goal of promoting and disseminating dermatological-related medical science knowledge to improve global health. Articles on clinical, laboratory, educational, and social research in dermatology and other related fields that are of interest to the medical profession are eligible for consideration. Review articles, original articles, brief reports, case reports and correspondence are accepted.